Loading...
XSWXMED
Market cap809mUSD
Dec 23, Last price  
53.50CHF
1D
4.49%
1Q
-1.65%
IPO
-14.40%
Name

Medartis Holding AG

Chart & Performance

D1W1MN
XSWX:MED chart
P/E
1,175.06
P/S
3.43
EPS
0.05
Div Yield, %
0.00%
Shrs. gr., 5y
2.85%
Rev. gr., 5y
11.81%
Revenues
212m
+15.96%
82,302,85092,502,392105,040,292121,324,702130,143,937127,645,985159,880,236182,824,418212,006,000
Net income
619k
P
7,270,9493,314,395866,5214,201,9072,146,521-943,5656,837,867-5,782,888619,000
CFO
20m
P
11,877,11711,908,64011,012,9946,449,4648,114,01712,610,80620,952,678-3,927,46019,962,000
Earnings
Mar 18, 2025

Profile

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
URL
https://www.medartis.com/
IPO date
Mar 23, 2018
Employees
858
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
212,006
15.96%
182,824
14.35%
159,880
25.25%
Cost of revenue
202,329
195,280
159,134
Unusual Expense (Income)
NOPBT
9,677
(12,456)
746
NOPBT Margin
4.56%
0.47%
Operating Taxes
1,174
(1,362)
1,452
Tax Rate
12.13%
194.55%
NOPAT
8,503
(11,094)
(706)
Net income
619
-110.70%
(5,783)
-184.57%
6,838
-824.68%
Dividends
Dividend yield
Proceeds from repurchase of equity
29,788
1,882
682
BB yield
Debt
Debt current
6,759
5,619
4,587
Long-term debt
47,551
46,418
38,975
Deferred revenue
21,872
1
Other long-term liabilities
27,792
4,064
19,978
Net debt
(5,148)
16,003
(55,671)
Cash flow
Cash from operating activities
19,962
(3,927)
20,953
CAPEX
(14,934)
(18,794)
(10,387)
Cash from investing activities
(37,832)
(52,913)
(15,874)
Cash from financing activities
23,215
(3,897)
(4,780)
FCF
13,581
(46,468)
(1,231)
Balance
Cash
25,201
20,605
82,642
Long term investments
34,257
15,430
16,591
Excess cash
48,858
26,894
91,239
Stockholders' equity
254,959
237,779
223,995
Invested Capital
261,279
266,612
176,383
ROIC
3.22%
ROCE
3.12%
0.28%
EV
Common stock shares outstanding
12,232
11,834
11,801
Price
Market cap
EV
EBITDA
30,676
5,656
17,133
EV/EBITDA
Interest
1,727
4,623
1,469
Interest/NOPBT
17.85%
196.90%